Labshake search
Citations for Shenandoah Biotechnology :
1 - 21 of 21 citations for MIF Macrophage migration inhibitory factor Mouse His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... bone marrow cells were grown in R10 media supplemented with 20 ng/mL mouse recombinant granulocyte-macrophage colony-stimulating factor (“GM-CSF”; 10822-026, Shenandoah Biotechnology). Fresh media was added on days 3 and 6 after plating ...
-
bioRxiv - Bioengineering 2020Quote: ... 1000 U/mL of Granulocyte-macrophage colony-stimulating factor (GM-CSF) (Shenandoah Biotechnology), and 500 U/mL of IL-4 (Shenandoah Biotechnology) ...
-
bioRxiv - Bioengineering 2022Quote: ... granulocyte-macrophage colony-stimulating factor (GM-CSF) 200-15 (Shenandoah BioTech, Warminster, PA). Mercaptoethanol (Thermofisher) ...
-
bioRxiv - Molecular Biology 2020Quote: ... mouse recombinant epidermal growth factor (EGF; 20 ng/ml) and basic fibroblast growth factor (bFGF; 20 ng/ml) (Shenandoah Biotechnology).
-
bioRxiv - Biochemistry 2022Quote: ... TF-1 cells were also supplemented with the 2 ng/ml Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) (Shenandoah Biotechnology, 100-08). Cells were incubated in a humidified incubator at 37°C with 5% CO2.
-
bioRxiv - Bioengineering 2023Quote: ... macrophages were treated with 20 ng/mL IL-4 (Shenandoah Biotech, Cat #200-18) and 20 ng/mL IL-13(Shenandoah Biotech ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/mL glial cell derived neurotrophic factor (Shenandoah Biotechnology), 1 mM dibutyryl cyclic adenosine monophosphate (MilliporeSigma) ...
-
bioRxiv - Cancer Biology 2021Quote: ... human growth factors (EGF, FGF, PDGF-AA, PDGF-BB [Shenandoah Biotechnology]) and heparin (Stemcell Technologies ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/mL brain derived neurotrophic factor (Shenandoah Biotechnology, Warwick, PA), 20 ng/mL glial cell derived neurotrophic factor (Shenandoah Biotechnology) ...
-
bioRxiv - Bioengineering 2022Quote: ... 100 ng/mL epidermal growth factor (EGF; Shenandoah Biotechnology #100-26-500UG), and 1% antibiotic-antimycotic 49 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL epidermal growth factor (EGF; Shenandoah Biotechnology #100-26-500UG). Following 5-7 days of differentiation ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/mL fibroblast growth factor 2 (Shenandoah Biotechnology, Part # 100-146). MSC used in subsequent experiments were at passage 6 (9-11 population doublings).
-
bioRxiv - Bioengineering 2021Quote: ... 10ng/mL insulin-like growth factor 1 (IGF-1; Shenandoah Biotechnology #100-34AF-100UG, Warminster, PA, USA) and 10 ng/mL epidermal growth factor (EGF ...
-
bioRxiv - Bioengineering 2022Quote: ... reduced serum medium with insulin-like growth factor 1 (IGF-1; Shenandoah Biotechnology #100-34, Warminster, PA, USA); reduced serum medium + additives with IGF-1 ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 10ng/mL insulin-like growth factor 1 (IGF-1; Shenandoah Biotechnology #100-34AF-100UG, Warminster, PA, USA), 100 ng/mL epidermal growth factor (EGF ...
-
bioRxiv - Immunology 2021Quote: ... Recombinant mouse Flt3 ligand (Flt3L) and mouse SCF were purchased from Shenandoah Biotech (Warwick, PA). Cells were stained with appropriate concentrations of mAbs ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant mouse Flt3 ligand (Flt3L) and mouse SCF were purchased from Shenandoah Biotech (Warwick, PA). Cells were stained with appropriate concentrations of mAbs ...
-
bioRxiv - Immunology 2021Quote: ... 1 µg/mouse of IL-15 (Shenandoah Biotech) was injected three times per week with an intraperitoneal injection (ip) ...
-
bioRxiv - Genomics 2020Quote: ... 16.7 ng/ml mouse M-CSF (Shenandoah Biotechnology) was added ...
-
bioRxiv - Neuroscience 2023Quote: ... and mouse M-CSF (Shenandoah Biotechnology, 200-08- 10, 1:1000). Cultures were treated with 100 ng/mL of either IFNγ ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were washed twice and supplemented either with no cytokines or with human (h) IL-2 (200 ng/ml) and mouse (m) mIL-12 (10 ng/ml) from Shenandoah Biotechnology alone or in combination every three days.